New Study Reveals Safe, Effective Therapy for Active Ulcerative Colitis

New Study Reveals Safe, Effective Therapy for Active Ulcerative Colitis
A new study conducted by an international research team recently revealed that the corticosteroid, beclomethasone dipropionate (BDP), can be successfully employed as a treatment strategy for patients with active mild-to-moderate ulcerative colitis. The study was published in The American Journal of Gastroenterology and is entitled “Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *